Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia

Bartzokis, George; Lu, Po H.; Nuechterlein, Keith H.; Gitlin, Michael; Doi, Clarissa; Edwards, Nancy; Lieu, Christopher; Altshuler, Lori L.; Mintz, Jim

doi:10.1016/j.schres.2007.02.011

« Previous Next »Schizophrenia Research
Volume 93, Issue 1 , Pages 13-22, July 2007

Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia☆

George Bartzokis
- Department of Neurology, The David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, United States
- Laboratory of Neuroimaging, Department of Neurology, Division of Brain Mapping, The David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, United States
- Greater Los Angeles VA Healthcare System, West Los Angeles, CA, 90073, United States
- Brain Research Institute, UCLA, Los Angeles, CA 90095, United States
- Corresponding author. UCLA Alzheimer's Disease Center, 710 Westwood Plaza, Room 2-238, Los Angeles, CA 90095-1769, United States. Tel.: +1 310 206 3207; fax: +1 310 268 3266.
Po H. Lu
- Department of Neurology, The David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, United States
- Greater Los Angeles VA Healthcare System, West Los Angeles, CA, 90073, United States
Keith H. Nuechterlein
- Department of Psychiatry and Biobehavioral Sciences, The David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, United States
- Department of Psychology, UCLA, Los Angeles, CA 90095, United States
Michael Gitlin
- Department of Psychiatry and Biobehavioral Sciences, The David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, United States
Clarissa Doi
- Department of Neurology, The David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, United States
- Greater Los Angeles VA Healthcare System, West Los Angeles, CA, 90073, United States
Nancy Edwards
- Department of Neurology, The David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, United States
- Greater Los Angeles VA Healthcare System, West Los Angeles, CA, 90073, United States
Christopher Lieu
- Department of Neurology, The David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, United States
- Greater Los Angeles VA Healthcare System, West Los Angeles, CA, 90073, United States
Lori L. Altshuler
- Department of Psychiatry and Biobehavioral Sciences, The David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, United States
- Department of Psychology, UCLA, Los Angeles, CA 90095, United States
Jim Mintz
- Department of Psychiatry and Biobehavioral Sciences, The David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, United States

Received 28 September 2006; received in revised form 14 February 2007; accepted 16 February 2007. published online 05 April 2007.

To access this article, please choose from the options below

☆ Presented in part at the Society of Biological Psychiatry's 60th Annual Meeting, Atlanta, GA, May 2005.

PII: S0920-9964(07)00102-8

doi:10.1016/j.schres.2007.02.011

Refers to erratum:

Erratum to “Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia”[Schizophrenia Research 93 (1–3) (2007) 13–22] , 18 October 2007
George Bartzokis, Po H. Lu, Keith H. Nuechterlein, Michael Gitlin, Clarissa Doi, Nancy Edwards, Christopher Lieu, Lori L. Altshuler, Jim Mintz
Schizophrenia Research February 2008 (Vol. 99, Issue 1, Page 379)
- Full Text
- PDF (84 KB)